IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Albemarle earnings fall YOY, but beat estimates

4:02 PM MST | January 28, 2014 | Vincent Valk

Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as reported by Thomson Reuters (New York). Adjusted earnings excluded a large pension benefit – including this benefit, earnings totaled $155.9 million, or $1.91/share. Net sales were up 0.6%, to $692 million, on higher volumes in polymers and catalysts. Catalysts segment sales were up 4% YOY, to $306.2 million, while segment income rose 2%, to $80.1 million. Strong volumes in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa